Bristol Myers Squibb has ended its R&D losing streak with a hit on one of the dual primary endpoints in a phase 3 multiple myeloma trial. But with the study continuing to evaluate the other primary ...
USA Rare Earth (NASDAQ:USAR) +5.9% pre-market Monday after saying it agreed to acquire rare earth metal and alloy producer LCM for $100 million in cash and 6.74 million shares of common stock, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback